There was a trend to deterioration in the placebo group but differences between treatments did not reach statistical significance.
← all excerpts
Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease.
1
—
—
There was a trend to deterioration in the placebo group but differences between treatments did not reach statistical significance.